Nan Qi Selected Research

clorprenaline (chlorprenaline)

3/2003

[Saccharomyces cerevisiae B5 efficiently and stereoselectively reduces 2'-chloroacetophenone to R-2'-chloro-1-phenylethanol in the presence of 5% ethanol].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nan Qi Research Topics

Disease

4	Virus Diseases (Viral Diseases) 01/2021 - 07/2015
2	Neoplasms (Cancer) 03/2017 - 11/2016
1	Lung Injury 04/2021
1	Acute Promyelocytic Leukemia 04/2021
1	Lung Diseases (Lung Disease) 04/2021
1	Carcinogenesis 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	COVID-19 01/2021
1	Starvation 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 05/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2020
1	Microsatellite Instability 02/2020
1	Tics (Tic) 02/2020
1	Endometrial Neoplasms (Endometrial Cancer) 02/2020
1	RNA Virus Infections 01/2019
1	Alcoholic Fatty Liver 10/2017
1	Wounds and Injuries (Trauma) 10/2017
1	Melanoma (Melanoma, Malignant) 03/2017
1	Heart Diseases (Heart Disease) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016
1	Malignant Pleural Effusion 11/2016
1	Autoimmune Hepatitis 01/2013
1	Liver Diseases (Liver Disease) 01/2013
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2013
1	Hepatitis 01/2013
1	Muscular Atrophy (Muscle Atrophy) 03/2011
1	Bronchitis 03/2003
1	Asthma (Bronchial Asthma) 03/2003

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2011
3	InterferonsIBA 01/2021 - 01/2019
3	Antiviral Agents (Antivirals)IBA 01/2021 - 07/2015
3	PrionsIBA 01/2021 - 07/2015
2	ArsenicIBA 04/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	Interferon Type IIBA 01/2021 - 07/2015
2	CytokinesIBA 01/2021 - 01/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2020 - 11/2016
2	Pharmaceutical PreparationsIBA 11/2016 - 03/2003
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2021
1	Apoptosis Regulatory ProteinsIBA 04/2021
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	LipidsIBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	CarcinogensIBA 01/2021
1	MetalloidsIBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	TNF Receptor-Associated Factor 3IBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2017
1	Peptides (Polypeptides)IBA 10/2017
1	Caspase 3 (Caspase-3)IBA 10/2017
1	HaptensIBA 03/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2017
1	InterleukinsIBA 03/2017
1	Recombinant ProteinsIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2016
1	Angiogenesis InhibitorsIBA 11/2016
1	Bevacizumab (Avastin)FDA Link 11/2016
1	Viral RNAIBA 07/2015
1	tyrosine receptor (receptor, tyrosine)IBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2011
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2011
1	UbiquitinIBA 03/2011
1	clorprenaline (chlorprenaline)IBA 03/2003

Therapy/Procedure

2	Immunotherapy 02/2020 - 03/2017
2	Drug Therapy (Chemotherapy) 02/2020 - 11/2016
1	Laser Therapy (Surgery, Laser) 03/2017
1	Lasers (Laser) 03/2017
1	Therapeutics 01/2017